Fact Check: Denmark Did NOT Announce 500% Export Tariff On Ozempic Sold In US In Response To Trump's Greenland Threats As Of January 31, 2025

Fact Check

  • by: Uliana Malashenko
Fact Check: Denmark Did NOT Announce 500% Export Tariff On Ozempic Sold In US In Response To Trump's Greenland Threats As Of January 31, 2025 Didn't Happen

Did Denmark announce a "500% tariff on exports of Ozempic to the USA" in January 2025? No, that's not true: The claim derived from a parody post on LinkedIn that lacked such a label. No credible media outlets reported the purported news.

The claim originated from a post (archived here) on LinkedIn, where it was published in early January 2025. It opened:

Press Release: Denmark's Weighty Response to Trumps's Greenland Threats - Tariff on Ozempic, Discounts for Canada

This is what it looked like on LinkedIn at the time of writing:

Screenshot 2025-01-31 at 2.15.00 PM.png

(Source: LinkedIn screenshot taken on Fri Jan 31 19:15:00 2025 UTC)

The post read:

COPENHAGEN - Denmark has taken a bold step in response to Donald Trump's fantasy of annexing Greenland. In a move sure to raise blood sugar levels, the Danish government announced a 500% tariff on exports of Ozempic to the USA. At the same time, Canada will get a 50% discount on the popular diabetes and weight-loss drug, because why not reward politeness?

The decision comes as Trump's latest musings about turning Greenland into 'the next Mar-a-Lago.' Danish Prime Minister Mette Frederiksen minced no words:

'Greenland is not for sale, but Ozempic is--for a hefty price in the U.S. While we love our American friends, it's time they understand sovereignty isn't negotiable, even if they're paying in Big Macs.'

Turning Up the Pressure--and the Scales.

Ozempic (archived here), a diabetes medicine known for its weight loss properties, is produced by the Danish company Novo Nordisk. The drug is widely prescribed in the United States (archived here).

The entry on LinkedIn reviewed in this article was published shortly after President Donald Trump, then still president-elect, promised in early January 2025 to "tariff Denmark at a very high level" (archived here) if it doesn't allow the U.S. to annex or acquire Greenland (archived here), which is presently an autonomous Danish territory.

The post's tone showed a significant deviation from the typically dry language of official government announcements, suggesting some form of parody or satire. However, no such labels were added to spell that out. Furthermore, other entries on social media mentioning the purported "500%" tariff on Ozempic -- for example, here (archived here) -- showed that some appear to have mistaken the proclamation on LinkedIn for an official press release of the Danish government.

As of January 31, 2025, Lead Stories found no evidence corroborating the claim.

The post on LinkedIn attributed the purported announcement to Denmark's Ministry of Foreign Affairs. However, its website showed no such press release published in 2025:

Screenshot 2025-01-31 at 3.56.16 PM.png

(Source: Ministry of Foreign Affairs of Denmark screenshot taken on Fri Jan 31 20:56:16 2025 UTC)

Furthermore, it didn't even mention Ozempic:

Screenshot 2025-01-31 at 4.08.31 PM.png

(Source: Ministry of Foreign Affairs of Denmark screenshot taken on Fri Jan 31 21:08:31 2025 UTC)

The Ministry's Trade Council (archived here), tasked with offering "up-to-date advisory support and expertise to Danish companies" selling their products abroad, said nothing about export tariffs on Ozempic as of this publication:

Screenshot 2025-01-31 at 4.15.51 PM.png

(Source: The Trade Council screenshot taken on Fri Jan 31 21:15:51 2025 UTC)

A search across news websites indexed by Google News showed zero articles corroborating the claim:

Screenshot 2025-01-31 at 4.21.04 PM.png

(Source: Google News screenshot taken on Fri Jan 31 21:21:04 2025 UTC)

Lead Stories also searched key phrases from the press release on Google and Google News, such as, "the Danish government announced a 500% tariff on exports of Ozempic to the USA," "Greenland is not for sale, but Ozempic is--for a hefty price in the U.S. While we love our American friends, it's time they understand sovereignty isn't negotiable, even if they're paying in Big Macs" (archived here) and "Canadians already have universal healthcare and low obesity rates" AND "Why not throw in cheaper Ozempic, eh" (archived here).

No results supported the authenticity of the press release. The search results are shown below:

Screenshot 2025-01-31 at 4.59.27 PM.png

(Source: Lead Stories screenshot taken Fri Jan 31 22:59:27  2025 UTC)

Read more

Other Lead Stories fact checks of the claims concerning international stories can be found here.

Lead Stories articles mentioning Europe are here.

Want to inform others about the accuracy of this story?

See who is sharing it (it might even be your friends...) and leave the link in the comments.:


  Uliana Malashenko

Uliana Malashenko joined Lead Stories as a freelance fact checking reporter in March 2022. Since then, she has investigated viral claims about U.S. elections and international conflicts in Gaza and Ukraine, among many other things. Before Lead Stories she spent over a decade working in broadcast and digital journalism, specializing in covering breaking news and politics. She is based in New York.

Read more about or contact Uliana Malashenko

About Us

International Fact-Checking Organization EFCSN Meta Third-Party Fact Checker

Lead Stories is a fact checking website that is always looking for the latest false, misleading, deceptive or inaccurate stories, videos or images going viral on the internet.
Spotted something? Let us know!.

Lead Stories is a:


WhatsApp Tipline

Have a tip or a question? Chat with our friendly robots on WhatsApp!

Add our number +1 (404) 655-4223, follow this link or scan the image below with your phone:

@leadstories

Subscribe to our newsletter

* indicates required

Please select all the ways you would like to hear from Lead Stories LLC:

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

Most Read

Most Recent

Share your opinion